50 likes | 57 Vues
The global biosurgery market is anticipated to grow at a CAGR of 6.8% during the forecast period. The major factors that are driving the growth of the market include an increasing number of surgeries and sports-related and trauma surgeries, rising demand for technologically upgraded surgical processes, and rising adoption of minimally invasive surgeries across the globe.
E N D
Orion Market Research Biosurgery Market, Size, Share, Analysis Report & Forecast to 2027 To Request a Sample of our Report on Biosurgery Market: https://www.omrglobal.com/request- sample/biosurgery-market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404
The global biosurgery market global biosurgery market is anticipated to grow at a CAGR of 6.8% during the forecast period (2021-2027). The key companies across the globe are focusing on the adoption of different growth strategies including capacity expansion, mergers and acquisitions, geographical expansion, new product launch, and product innovation to remain competitive in the marketplace. For instance, in September 2020, Takeda Pharmaceuticals co. ltd. has done an agreement with Corza Health Inc., to divest its TachoSil Fibrin Sealant Patch. This fibrin sealant patch is a surgical patch to deliver safe, fast, and reliable bleeding control. Takeda Pharmaceutical Company received around $421 million in cash for divesting its TachoSil to Corza Health. (Get 15% Discount on Buying this Report) A full Report of Biosurgery Market is Available at: https://www.omrglobal.com/industry- reports/biosurgery-market Moreover, in September 2020, CryoLife, Inc., a cardiac and vascular surgery company focused on aortic disease, has announced that it has acquired Ascyrus Medical LLC, a Florida-based company. Ascyrus’s first aortic arch remodeling device named Ascyrus Medical Dissection Stent used for the treatment of Type A aortic dissections. Apart from it, in October 2018, Atrium Medical Corporation, a subsidiary of Getinge, has done an agreement to divest its biosurgery business to HJ Capital 1, the parent company of SeCQure Surgical Corporation, a medical device company. In December 2019, Johnsons & Johnsons, a medical devices company, has announced that Ethicon has launched VISTASEAL Fibrin Sealant (Human) to assist surgeons to manage bleeding during surgery. It is a combination of fibrinogen and thrombin, clotting proteins found in human plasma. When applied to the bleeding portion, it forms adherent, and durable clots and assist to sustain hemostasis (stoppage of bleeding), even in high-risk patients. However, the key player's strategies such as the expansion of its product distribution by making new agreements, launches of new products, and mergers and acquisitions in the market are to drive the global biosurgery market during the forecast period. Market Coverage • The market number available for – 2020-2027 • Base year- 2020 • Forecast period- 2021-2027 Segment Covered- • By Product • By Application Regions Covered- • North America • Europe • Asia-Pacific • Rest of the World •Competitive Landscape- Baxter International Inc., B. Braun Melsungen AG, Cohera Medical, Inc., CryoLife Inc., CSL Limited (CSL Behring), Johnson & Johnson (Ethicon, Inc.), among others To Request a Sample of our Report on Biosurgery Market: https://www.omrglobal.com/request- sample/biosurgery-market
Global Biosurgery Market Report Segment By Products •Adhesion Barriers •Soft Tissue Management (mesh/patch) •Biological •Synthetic Bone graft substitutes •Cell-based matrices •Bone morphogenetic proteins •Demineralized bone matrix •Synthetic graft extender Surgical Sealants •Fibrin Sealants •Collagen Based Adhesives •Synthetic agents •Tissue –Adhesive Glues •Hemostatic Agents •Staple Line Reinforcement Static Agents By Application • Neurological Surgeries • General Surgeries • Cardiovascular Surgeries • Orthopedic Surgeries • Gynecology Surgeries • Urological Surgery • Thoracic Surgeries • Others (Ophthalmic Surgeries) Regional Analysis North America •United States •Canada Europe •UK •Germany •Spain •France •Italy •Rest of Europe
Asia-Pacific •India •China •Japan •Rest oF APAC Rest of The World •Middle East & Africa •Latin America Company Profiles •Aroa Biosurgery Ltd. •Atrium Medical Corp. •B. Braun Melsungen AG •Baxter International, Inc. •Becton, Dickinson, and Co. (BD) •Biom’Up USA, Inc. •Cohera Medical, Inc. •CSL Ltd. •CryoLife, Inc. •Ethicon US, LLC (Johnson & Johnson) •Hemostasis, LLC •Integra LifeSciences Corp. •Kuros BiosciencesA.G. •MAQUET Holding B.V. & Co. Kg. (Getinge AB) •Medtronic Plc •Osiris Therapeutics, Inc. •Pfizer Inc. •Sanofi SA •Stryker Corp. •Takeda Pharmaceutical Co. Ltd. Reasons for Buying from us – 1. We cover more than 15 major industries, further segmented into more than 90 sectors. 2. More than 120 countries are for analysis. 3. Over 100+ paid data sources mined for investigation. 4. Our expert research analysts answer all your questions before and after purchasing your report. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/biosurgery-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 7803040404